Video

Titilope Fasipe, MD, PhD: Treating and Living With Sickle Cell Disease

Author(s):

Dr. Fasipe shares her in-person experience viewing Phillip Okwo's Life Interrupted production about living with sickle cell disease.

Not only does she treat sickle cell disease, but Titilope Fasipe, MD, PhD, Assistant Professor of Pediatric Hematology-Oncology, Baylor College, also lives with it.

She was invited to watch a live performance that displayed what it's like to live with sickle cell disease. Phillip Okwo lives with the disease himself and decided to share his experience with the world and create Life Interrupted.

"By the time it got to the end, I was really emotional," Dr. Fasipe said. She shared what it was like for her to witness the performance first-hand.

The performance shows 4 different scenes that are based on real-life experiences from different times in Okwo's life, all in under 4 minutes. Actors play various roles in these experiences as well as the younger version of himself, but Okwo plays himself as an adult.

Each scene is an example of how a vaso-occlusive crisis (VOC) or a "pain crisis" can interrupt the life of someone who lives with sickle cell disease. The pain crisis can start at any time. Not only do patients have to endure the pain, but also the anxiety that comes with it.

After the scenes are over, Okwo comes right off the stage and leads a thoughtful discussion with the doctors that just viewed the performance. Watch the full performance below.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
© 2024 MJH Life Sciences

All rights reserved.